FDA Inspection 1229815 — Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC — FEI 1811396

The FDA completed an inspection of Catalent Pharma Solutions, LLC on May 30, 2024 in Saint Petersburg, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 30, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Petersburg, FL (United States)